EcoDrugPlus

Aurora Kinase A

Ensembl ID : ENSAOCG00000007078
Gene Symbol: AURKA
3 Cross references
230 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSAOCG00000008896
Gene Symbol: LOC111586350
3 Cross references
205 Possible Orthologues:

Beta-1 Adrenergic Receptor-Like

Ensembl ID : ENSAOCG00000015216
Gene Symbol: LOC111579818
3 Cross references
197 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSAOCG00000015368
Gene Symbol: LOC111588061
3 Cross references
196 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSAOCG00000015967
Gene Symbol: BACE1
3 Cross references
221 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSAOCG00000001284
Gene Symbol: BDKRB2
1 Cross references
231 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSAOCG00000018079
Gene Symbol: BDKRB2
3 Cross references
231 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSAOCG00000018087
Gene Symbol: BDKRB2
4 Cross references
231 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSAOCG00000018024
Gene Symbol: BDKRB2
2 Cross references
182 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b-Like

Ensembl ID : ENSAOCG00000024638
Gene Symbol: LOC111587648
2 Cross references
224 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4c-Like

Ensembl ID : ENSAOCG00000004647
Gene Symbol: LOC111587651
3 Cross references
180 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSAOCG00000002065
Gene Symbol: CASR
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).